Close

Steven Bellan

Assistant Professor

Education

Affiliations

Projects

Papers

Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr., Brisson M, Mahon BE, Henao-Restrepo AM. (2019). An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool. Vaccine, 37(31)

Mercaldo RA, Bellan SE. (2019). Evaluation of alternative endpoints for ZIKV vaccine efficacy trials. Vaccine, 37(15)

Shen M, Xiao Y, Rong L, Meyers LA, Bellan SE. (2018). The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco. BMC medicine, 16(1)

Hitchings MDT, Lipsitch M, Wang R, Bellan SE. (2018). Competing Effects of Indirect Protection and Clustering on the Power of Cluster-Randomized Controlled Vaccine Trials. American journal of epidemiology, 187(8)

Shen M, Xiao Y, Rong L, Meyers LA, Bellan SE. (2017). Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance. Proceedings. Biological sciences, 284(1857)

Means AR, Risher KA, Ujeneza EL, Maposa I, Nondi J, Bellan SE. (2017). Correction: Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database. PLoS One, 12(1)

Means AR, Risher KA, Ujeneza EL, Maposa I, Nondi J, Bellan SE. (2016). Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database. PLoS One, 11(10)

Sempa JB, Dushoff J, Daniels MJ, Castelnuovo B, Kiragga AN, Nieuwoudt M, Bellan SE. (2016). Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan Cohort. American journal of epidemiology, 184(1)

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J. (2015). Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. The Lancet. Infectious diseases, 15(6)